Skip to content
hcg-service-hero-1

Insights From Halloran

Mary Malloy Ursprung, PhDJul 18, 2022 9:03:00 PM6 min read

Tips For Clinical Trial Sponsors To Cultivate Relationships With Sites

“Tips For Clinical Trial Sponsors To Cultivate Meaningful Relationships With Sites” was ...
Start Reading
Halloran Consulting GroupJul 12, 2022 4:44:00 PM9 min read

Managing Clinical Trials So They Don’t Break the Bank

I recently partnered with Laurie Halloran, President & CEO of Halloran Consulting ...
Start Reading
Halloran Consulting GroupJun 28, 2022 12:00:00 AM3 min read

Competitive Intelligence: How to Get an Edge Over Your Competitors

On April 19, 2022, experts from Halloran’s Strategy and Program Leadership team (Anmol ...
Start Reading
Genna JenkinsJun 14, 2022 4:39:00 PM6 min read

FDA Denies Additional China-Developed Oncology Drugs

The U.S. Food and Drug Administration (FDA) declined approval for two additional ...
Start Reading
Halloran Consulting GroupJun 7, 2022 2:23:00 PM6 min read

Building Effective Patient Retention Strategies Early in Study Design

“The Dropout: Building Effective Patient Retention Strategies Early in Study Design” by ...
Start Reading
Halloran Consulting GroupMay 31, 2022 1:57:00 PM5 min read

Set Up for Success: Selecting Your CRO and Decentralized Vendors

“Set Your Trial Up for Success—Select Your CRO and Decentralized Vendors in Parallel” by ...
Start Reading
Halloran Consulting GroupMay 17, 2022 11:49:00 AM7 min read

Scalable Considerations to Avoid Clinical Research Pitfalls

Clinical research would not be possible without the participation of patients who donate ...
Start Reading
Halloran Consulting GroupMay 12, 2022 8:54:00 AM8 min read

Current State of Clinical Trials Impacted by the War in Ukraine

Current State of Clinical Trials Impacted by the War in Ukraine is Part One of a ...
Start Reading
Halloran Consulting GroupMay 9, 2022 12:43:00 PM5 min read

Steps Organizations Can Take to Enable Better Patient Representation

“Health Inequities and the Path Ahead: Panel Shares Small Steps Organizations Can Take to ...
Start Reading
Nicole GalloMay 9, 2022 11:21:00 AM6 min read

FDA Requires Randomized Data to Support PI3K Inhibitor Approvals

The Oncologic Drugs Advisory Committee (ODAC) convened a meeting on April 21, 2022, to ...
Start Reading